The economic burden of prostate cancer – a Swedish prevalence-based register study

BACKGROUND: Incidence and prevalence of prostate cancer in Sweden have increased markedly due to prostate-specific antigen (PSA) testing. Moreover, new diagnostic tests and treatment technologies are expected to further increase the overall costs. Our aims were (i) to estimate the societal costs for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Shuang, Östensson, Ellinor, Eklund, Martin, Grönberg, Henrik, Nordström, Tobias, Heintz, Emelie, Clements, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238534/
https://www.ncbi.nlm.nih.gov/pubmed/32434566
http://dx.doi.org/10.1186/s12913-020-05265-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238534/
https://www.ncbi.nlm.nih.gov/pubmed/32434566
http://dx.doi.org/10.1186/s12913-020-05265-8

Ejemplares similares